ITGA2 and posterior cortical atrophy: The results showed that the patient group with tumors expressing lower levels of ITGA1/ITGA2 had increased risk of biochemical relapse and metastasis in multiple independent PCa cohorts (Figure 2h–k; Figure S2g,h,j,k, Supporting Information).